Literature DB >> 15273143

CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.

V Miriagou1, L S Tzouvelekis, L Villa, E Lebessi, A C Vatopoulos, A Carattoli, E Tzelepi.   

Abstract

An IncN plasmid (p541) from Escherichia coli carried a Citrobacter freundii-derived sequence of 4,252 bp which included an ampC-ampR region and was bound by two directly repeated IS26 elements. ampC encoded a novel cephalosporinase (CMY-13) with activity similar to that of CMY-2. AmpR was likely functional as indicated in induction experiments.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15273143      PMCID： PMC478546          DOI： 10.1128/AAC.48.8.3172-3174.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: detection in a complex beta-lactamase background.

Authors:  Mark D Reisbig; Nancy D Hanson
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

3.  Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum beta-lactamase gene and a class 1 integron.

Authors:  L Villa; C Pezzella; F Tosini; P Visca; A Petrucca; A Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1.

Authors:  S Vourli; L S Tzouvelekis; E Tzelepi; E Lebessi; N J Legakis; V Miriagou
Journal:  FEMS Microbiol Lett       Date:  2003-08-08       Impact factor: 2.742

5.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae.

Authors:  N Fortineau; L Poirel; P Nordmann
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

Review 7.  Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae.

Authors:  N D Hanson; C C Sanders
Journal:  Curr Pharm Des       Date:  1999-11       Impact factor: 3.116

8.  Nucleotide sequence of IS26, a new prokaryotic mobile genetic element.

Authors:  B Mollet; S Iida; J Shepherd; W Arber
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

9.  Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.

Authors:  G Barnaud; G Arlet; C Verdet; O Gaillot; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

10.  Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191
View more
  17 in total

1.  VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Leonidas S Tzouvelekis; Despoina Tokatlidou; Nicholas Spanakis; Antonios N Maniatis; Nicholas J Legakis; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.

Authors:  Sonia Ktari; Guillaume Arlet; Basma Mnif; Valérie Gautier; Fouzia Mahjoubi; Mounir Ben Jmeaa; Mounir Bouaziz; Adnane Hammami
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

3.  Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.

Authors:  Amber J Schmidtke; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.

Authors:  Marco M D'Andrea; Elisabetta Nucleo; Francesco Luzzaro; Tommaso Giani; Roberta Migliavacca; Francesca Vailati; Vesselina Kroumova; Laura Pagani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii.

Authors:  Charlotte Verdet; Yahia Benzerara; Valérie Gautier; Olivier Adam; Zahia Ould-Hocine; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Zoo animals as reservoirs of gram-negative bacteria harboring integrons and antimicrobial resistance genes.

Authors:  Ashraf M Ahmed; Yusuke Motoi; Maiko Sato; Akito Maruyama; Hitoshi Watanabe; Yukio Fukumoto; Tadashi Shimamoto
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

7.  IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids.

Authors:  Vivi Miriagou; Alessandra Carattoli; Eva Tzelepi; Laura Villa; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.

Authors:  Kenichi Kaneko; Ryoichi Okamoto; Ryuichi Nakano; Sayoko Kawakami; Matsuhisa Inoue
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

9.  Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.

Authors:  Misty D Balcewich; Keith A Stubbs; Yuan He; Terrence W James; Gideon J Davies; David J Vocadlo; Brian L Mark
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 10.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.